333 related articles for article (PubMed ID: 12461659)
21. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Guttmann RD; Flemming C
Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
[TBL] [Abstract][Full Text] [Related]
22. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study.
Opelz G
Kidney Int Suppl; 1995 Dec; 52():S89-92. PubMed ID: 8587292
[TBL] [Abstract][Full Text] [Related]
23. Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone.
Moran M; Mozes MF; Maddux MS; Veremis S; Bartkus C; Ketel B; Pollak R; Wallemark C; Jonasson O
N Engl J Med; 1990 Apr; 322(17):1183-8. PubMed ID: 2109195
[TBL] [Abstract][Full Text] [Related]
24. A comparison of two cyclosporine protocols at the University of Minnesota.
Fryd DS; Canafax DM; Matas AJ; Dunn D; Payne WD; Sutherland DE; Najarian JS
Clin Transpl; 1988; ():79-90. PubMed ID: 3154498
[TBL] [Abstract][Full Text] [Related]
25. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
[TBL] [Abstract][Full Text] [Related]
26. [Kidney-pancreas transplantation. Clinical results in 23 consecutive patients].
Maestri M; Krieger N; Kuo P; Dafoe DC; Alfrey EJ
Minerva Chir; 1998 Mar; 53(3):121-8. PubMed ID: 9617106
[TBL] [Abstract][Full Text] [Related]
27. Improved results in high risk cadaveric kidney transplantation.
Toledo-Pereyra LH; Baskin S; McNichol L; Edford G; Whitten J; Allaben R
Proc Clin Dial Transplant Forum; 1980; 10():289-92. PubMed ID: 7050990
[TBL] [Abstract][Full Text] [Related]
28. Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens.
McIntyre HD; Menzies B; Rigby R; Perry-Keene DA; Hawley CM; Hardie IR
Clin Transplant; 1995 Feb; 9(1):20-4. PubMed ID: 7742578
[TBL] [Abstract][Full Text] [Related]
29. Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine.
Hall BM; Tiller DJ; Hardie I; Mahony J; Mathew T; Thatcher G; Miach P; Thomson N; Sheil AG
N Engl J Med; 1988 Jun; 318(23):1499-507. PubMed ID: 3285215
[TBL] [Abstract][Full Text] [Related]
30. The effect of immunosuppressive drugs on quality of life after renal transplantation.
Hilbrands LB; Hoitsma AJ; Koene RA
Transplantation; 1995 May; 59(9):1263-70. PubMed ID: 7762059
[TBL] [Abstract][Full Text] [Related]
31. Antilymphocyte globulin in cadaveric renal transplantation--a controlled trial.
Jakobsen A; Sødal G; Flatmark A; Thorsby E
Scand J Urol Nephrol Suppl; 1977; (42):94-6. PubMed ID: 356233
[TBL] [Abstract][Full Text] [Related]
32. Do cyclosporin profiles provide useful information in the management of renal transplant recipients?
Bowles MJ; Waters JB; Lechler RI; Williams G
Nephrol Dial Transplant; 1996 Aug; 11(8):1597-602. PubMed ID: 8856218
[TBL] [Abstract][Full Text] [Related]
33. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
Sandborn WJ; Hay JE; Porayko MK; Gores GJ; Steers JL; Krom RA; Wiesner RH
Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
[TBL] [Abstract][Full Text] [Related]
34. Predictors of improved outcome in second pediatric renal transplant recipients.
Moss A; Almond PS; Matas AJ; Gillingham K; Najarian JS
Transplant Proc; 1993 Feb; 25(1 Pt 1):597. PubMed ID: 8438429
[No Abstract] [Full Text] [Related]
35. Cost containment: coadministration of diltiazem with cyclosporine after heart transplantation.
Valantine H; Keogh A; McIntosh N; Hunt S; Oyer P; Schroeder J
J Heart Lung Transplant; 1992; 11(1 Pt 1):1-7; discussion 7-8. PubMed ID: 1540597
[TBL] [Abstract][Full Text] [Related]
36. A prospective randomised comparative study on the influence of cyclosporin and azathioprine on renal allograft survival and function.
Henny FC; Kootte AM; Van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
Nephrol Dial Transplant; 1986; 1(1):44-9. PubMed ID: 3110662
[TBL] [Abstract][Full Text] [Related]
37. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
[TBL] [Abstract][Full Text] [Related]
38. Cyclosporine alone or in combination with prednisone in cadaveric renal transplantation.
Thiel G; Harder F; Loertscher R; Brünisholz M; Landmann J; Brunner F; Follat F; Wenk M; Mihatsch M
Transplant Proc; 1984 Oct; 16(5):1187-90. PubMed ID: 6385374
[TBL] [Abstract][Full Text] [Related]
39. Kidney transplantation in the older patient.
Peters TG; Charlton RK; Jones KW; Goodrich JP; Sill TM; King TB
J Fla Med Assoc; 1994 Aug; 81(8):535-8. PubMed ID: 7964580
[TBL] [Abstract][Full Text] [Related]
40. A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function.
Slakey DP; Johnson CP; Callaluce RD; Browne BJ; Zhu YR; Roza AM; Adams MB
Transplantation; 1993 Oct; 56(4):827-31. PubMed ID: 8212201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
